Modern approaches to pretransfusion testing

[1]Oberman HA. Judd Wj. Cost-containment in transfusion practice: a view from the United States. In: Cash JD, ed. Progress in transfusion medicine. 3rd ed. Edinburgh, Scotland: Churchill Livingstone, 1988:145-58.Search in Google Scholar

[2]Smith DM, Judd WJ, eds. Blood banking in a changing environment. Arlington, VA: American Association of Blood Banks, 1984.Search in Google Scholar

[3]Issitt PD. The impact of monoclonal antibodies in blood group serology. Transfusion 1989;29:58-64.10.1046/j.1537-2995.1989.29189101166.x2643211Search in Google Scholar

[4]Nance SJ, Garratty G.A new potentiator of red blood cell antigen-antibody reactions. Am J Clin Pathol 1987;87:633-5.10.1093/ajcp/87.5.6333578138Search in Google Scholar

[5]Plapp FV, Sinor LT, Rachel JM, et al. A solid phase antibody screen. Am J Clin Pathol 1984;82:719-21.10.1093/ajcp/82.6.7196507384Search in Google Scholar

[6]Lapierre Y Rigal D, Adam J, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990;30:109-13.10.1046/j.1537-2995.1990.30290162894.x2305438Search in Google Scholar

[7]Butch SH, Judd WJ, Steiner EA, Stoe M, Oberman HA. Electronic verification of donor-recipient compatibility: the computer crossmatch. Transfusion 1994; 34:105-9.10.1046/j.1537-2995.1994.34294143935.x8310478Search in Google Scholar

[8]Shulman IA. Comprehensive transfusion medicine survey J-B [final critique]. Northfield, IL: College of American Pathologists; 1985.Search in Google Scholar

[9]Sazama KS, Shulman IA. Transfusion medicine (comprehensive, limited) survey set J-A [final critique]. Northfield, IL: College of American Pathologists; 1998.Search in Google Scholar

[10]Maffei LM, Johnson ST, Shulman IA, Steiner EA. Pretransfusion testing survey. Transfusion 1998; 38:343-9.10.1046/j.1537-2995.1998.38498257372.x9595016Search in Google Scholar

[11]Judd WJ, Butch SH. Cost-containment in the blood bank: eliminating unnecessary serological testing. J MedTechnol 1984;1:484-95.Search in Google Scholar

[12]Garratty G. The significance of complement in immunohematology. CRC Crit Rev Clin Lab Sci 1984;20:25-56.10.3109/104083684091657696373144Search in Google Scholar

[13]Low B, Messeter L. AHG tests in low-ionic strength salt solutions for rapid antibody screening and crossmatching. Vox Sang 1974;26:53-61.10.1111/j.1423-0410.1974.tb02666.x4420622Search in Google Scholar

[14]Mołlison PL. Blood transfusion in clinical medicine. 5th ed. Oxford, England: Blackwell Scientific Publications, 1972.Search in Google Scholar

[15]Issitt PD. Antibodies reactive at 30° centigrade, room temperature and below: a technical workshop. In: Butch SH, ed. Clinically significant and insignificant antibodies: a technical workshop. Washington, DC: American Association of Blood Banks, 1979:13-28.Search in Google Scholar

[16]Wright MS, Issitt PD. Anticomplement and the indirect AHG test. Transfusion 1979;19:688-94.10.1046/j.1537-2995.1979.19680104094.x118556Search in Google Scholar

[17]Howard JE, Winn LC, Gottlieb CE, Grumet FC, Garratty G, Petz LD. Clinical significance of the anticomplement component of AHG antisera. Transfusion 1982;22:269-72.10.1046/j.1537-2995.1982.22482251204.x6980506Search in Google Scholar

[18]Judd WJ, Butch SH, Oberman HA, Steiner EA, Bauer RC. The evaluation of a positive direct AHG test in pretransfusion testing. Transfusion 1980;20:17-23.10.1046/j.1537-2995.1980.20180125036.x6986682Search in Google Scholar

[19]Judd WJ, Barnes BA, Steiner EA, Oberman HA, Averill DB, Butch SH. The evaluation of a positive direct AHG test in pretransfusion testing revisited. Transfusion 1986;26:220-4.10.1046/j.1537-2995.1986.26386209372.x3705135Search in Google Scholar

[20]Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the crossmatch in urgent or massive transfusion. Transfusion 1978; 18:137-41.10.1046/j.1537-2995.1978.18278160574.x417431Search in Google Scholar

[21]Oberman HA, Barnes BA, Steiner EA. Role of the crossmatch in testing for serologic incompatibility. Transfusion 1982;22:12-6.10.1046/j.1537-2995.1982.22182154207.x6801826Search in Google Scholar

[22]Judd WJ. Testing for unexpected red cell antibodies—two or three reagent red cell samples. Immunohematology 1997;13:90-2.10.21307/immunohematology-2019-714Search in Google Scholar

[23]Shulman IA, Nelson JM, Okamoto M, Malone SA. The dependence of anti-Jk^a detection on screening cell zygosity. Lab Med 1985;16:602-4.10.1093/labmed/16.10.602Search in Google Scholar

[24]Shulman IA, Yaowasiriwatt M, Saxena S, Nelson JM. Influence of reagent red cell zygosity on anti-Fy¹ detection. Lab Med 1989; 20:37-9.10.1093/labmed/20.1.37Search in Google Scholar

[25]Fitzsimmons JM, Morel PA. The effects of red blood cell suspending media on hemagglutination and the AHG test. Transfusion 1979;19:81-5.10.1046/j.1537-2995.1979.19179160273.x432916Search in Google Scholar

[26]Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical blood order schedules. Transfusion 1977;17:163-8.10.1046/j.1537-2995.1977.17277151923.x403642Search in Google Scholar

[27]Friedman BA, Oberman HA, Chadwick AR, Kingdon KI. The maximal surgical blood order schedule and surgical blood use in the United States. Transfusion 1976;16:380-7.10.1046/j.1537-2995.1976.16476247063.x951737Search in Google Scholar

[28]Garratty G. The role of compatibility tests (rapid communication). Transfusion 1982;22:169-72.10.1046/j.1537-2995.1982.22282177132.x6803410Search in Google Scholar

[29]Food and Drug Administration. FDA memorandum to all registered blood establishments: equivalent methods for compatibility testing. December, 1984.Search in Google Scholar

[30]Code of federal regulations. Current edition. Title 21. Subparts 606 and 640. Washington, DC: U.S. Government Printing Office.Search in Google Scholar

[31]Menitove J, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda, MD: American Association of Blood Banks, 1998.Search in Google Scholar

[32]Judd WJ, Steiner EA, Oberman HA, Nance SJ. Can the reading for serological reactivity following 37°C incubation be omitted? Transfusion 1992;32:304-8.10.1046/j.1537-2995.1992.32492263441.x1585433Search in Google Scholar

[33]JuddWJ, Steiner EA, Knafĩ PC. The gel test: sensitivity and specificity for unexpected antibodies to blood group antigens. Immunohematology 1997;13:132-5.10.21307/immunohematology-2019-728Search in Google Scholar

[34]Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda, MD:American Association of Blood Banks, 1996.Search in Google Scholar

[35]Judd WJ, Fullen DR, Steiner EA, Davenport RD, Knafĩ PC. Revisiting the issue: can the reading for serologic reactivity following 37°C incubation be omitted? Transfusion (in press).Search in Google Scholar

[36]Beck ML, Yates AD, Hardman J, Kowalski MA. Identification of a subset of group B donors identified with a monoclonal anti-A reagent. Am J Clin Pathol 1989;92:625-9.10.1093/ajcp/92.5.6252510496Search in Google Scholar

[37]Beck ML, Kowalski MA, Kirkegaard JR, Korth JL. Unexpected reactivity with monoclonal anti-B reagents. Immunohematology 1992;8:22-3.Search in Google Scholar

[38]JuddWJ, Steiner EA, Oberman HA, Giacherio D. Falsepositive results with chemically modified anti-D do not indicate the need for a separate immunologically inert Rh control reagent. Transfusion 1988;28: 339-41.10.1046/j.1537-2995.1988.28488265262.x3133845Search in Google Scholar

[39]Judd WJ. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific Publications, 1994.Search in Google Scholar

[40]Champagne K, Spruell P, Chen J, et al. Comparison of affinity column technology and USS tube tests. Immunohematology 1998;14:149-51.10.21307/immunohematology-2019-684Search in Google Scholar

[41]Judd WJ, Steiner EA, O’Donnell DB, Oberman HA. Discrepancies in ABO typing due to prozone: how safe is the immediate-spin crossmatch? Transfusion 1988;28:334-8.10.1046/j.1537-2995.1988.28488265261.x3388479Search in Google Scholar

[42]Voak D. Observations on the rare phenomenon of anti-A prozone and the non-specific blocking of hemagglutination due to Cl complement fixation of IgG anti-A antibodies. Vox Sang 1972;22:408-19.Search in Google Scholar

[43]Judd WJ.’New’ blood bank technologies. Clin Lab Sci 1998;11:106-13.Search in Google Scholar

[44]Reilly B, DePalma H, Cosgrove P, Parsi M, Grima K. Comparison between routine tube test (LISS), PEG tube test, gel technology and solid-phase red cell adherence assays (abstract). Transfusion 1997; 37:648.Search in Google Scholar

[45]ĩssitt PD, Combs MR, Bradshaw T. Comparison of a solid phase and polyethylene’ glycol (PEG) IAT method in a large transfusion service (abstract). Transfusion 1997;37:28S.Search in Google Scholar

[46]Allen J, ĩssitt PD, Combs MR. Detection of weak complement-binding antibodies in polyethylene glycol (PEG>IATs read with anti-IgG service (abstract). Transfusion 1997;37:28S.Search in Google Scholar

[47]Alkahasan AA, Combs MR, Ĩssitt PD. Detection of 37°C agglutinins by polyethylene glycol (PEG>IAT (abstract). Transfusion 1997;37:28S.Search in Google Scholar

[48]ĩssitt PD, Combs MR, Booth K. Comparison of the MTS-gel and polyethylene glycol (PEG) IAT methods (abstract). Transfusion 1997;37:64S.Search in Google Scholar

[49]Lown J, Willis J. Monocyte monolayer assay (MMA) reactivity of alloantibodies reacting by the manual polybrene technique but not by an antiglobulin test. Transfus Med 1995;5:281-4.10.1111/j.1365-3148.1995.tb00215.x8646292Search in Google Scholar

[50]Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions. Arlington, VA: American Association of Blood Banks, 1982:91-119.Search in Google Scholar

[51]Lalezari P Jiang AF. The manual Polybrene® test: a simple and rapid procedure for detection of red cell antibodies. Transfusion 1980;20:206-11.10.1046/j.1537-2995.1980.20280169962.x6768173Search in Google Scholar

[52]Judd WJ. Requirements for the electronic crossmatch. Vox Sang 1998;74(S2):409-17.10.1111/j.1423-0410.1998.tb05450.x9704475Search in Google Scholar

[53]Judd WJ. The electronic crossmatch: an alternative to the immediate-spin crossmatch to detect ABO incompatibility. Advance 1998;10(15):16-23.Search in Google Scholar

[54]Sawfenberg J, Hogman CF, Cassemar B. Computerized delivery control—a useful and safe complement to the type and screen compatibility testing. Vox Sang 1997;72:162-8.10.1046/j.1423-0410.1997.7230162.xSearch in Google Scholar

[55]Cox C, Enno A, Deveridge S, et al. Remote electronic release blood system. Transfusion 1997;37:960-4.10.1046/j.1537-2995.1997.37997454025.xSearch in Google Scholar

[56]ChanA, Chan JC,Wong LY Cheng G. From maximum surgical blood ordering schedule to unlimited computer crossmatching: evolution of blood transfusion for surgical patients at a tertiary hospital in Hong Kong. Transfus Med 1996;6:121-4.10.1046/j.1365-3148.1996.d01-60.xSearch in Google Scholar

[57]British Committee for Standardization in Haematology, Blood Transfusion Task Force. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 1996;6:273-83.10.1111/j.1365-3148.1996.tb00079.xSearch in Google Scholar

[58]Georgsen J, Jensen Ę Jeppesen S, Rasmussen L, Kristensen T. Transfusion service of the county of Funen. Organizational and economic aspects of restructuring. Ugeskrift for Laeger 1997; 159:1758-62.Search in Google Scholar

[59]Barratt PG, Russel PG, Rowell JA. Eighteen months experience with a “computer crossmatch”—minus the computer (abstract). Transfusion 1993;33:748.Search in Google Scholar

[60]Computer Crossmatch Reviewer’s Checklist. U.S. Food and Drug Administration’s Center for Biologies Evaluation and Research. Rockville, MD; 1997.Search in Google Scholar

[61]Steane EA, Steane SM, Montgomery SR, Pearson JR. A proposal for compatibility testing incorporating the manual hexadimethrine bromide (Polybrene®) test. Transfusion 1985;25:176-8.10.1046/j.1537-2995.1985.25686071426.xSearch in Google Scholar

[62]Berry-Dortch S, Woodside C, Boral Lĩ. Limitations of the immediate spin crossmatch when used for detecting ABO incompatibility. Transfusion 1985;25:540-4.10.1046/j.1537-2995.1985.25285169217.xSearch in Google Scholar

[63]Triulzi DJ, Portman WH, Mango PD, Lopez-Plaza 1, Hahn LF. Centralized transfusion service: a novel approach to the delivery of transfusion services. Transfus Med Rev 1995;9:123-30.10.1016/S0887-7963(05)80051-3Search in Google Scholar